Take part in a paid clinical trial

The investigational treatment is being developed as a potential future therapy for inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn’s disease (CD). This is the first step in evaluating the treatment’s safety and how it behaves in the body before testing its effectiveness in patients with these conditions. 

This study is investigating a potential treatment for people living with chronic kidney disease. This is a healthy volunteer participant study.

Chronic kidney disease (CKD) is a long-term condition where the kidneys gradually lose their ability to filter waste and excess fluids from the blood. This can lead to a buildup of toxins in the body, causing health issues such as fatigue, swelling, and high blood pressure. CKD often develops slowly over time, sometimes without noticeable symptoms in the early stages, and is commonly linked to conditions like diabetes and hypertension. While it cannot always be cured, early detection and management can help slow its progression, improve quality of life, and reduce the risk of serious complications. 

We’re testing a potential new treatment designed to help people living with conditions where the immune system mistakenly attacks the body’s own cells. This study aims to better understand how the therapy interacts with the immune system and whether it can help reduce unwanted immune responses.

This clinical study is part of a first-in-human trial focused on metabolic health. Researchers are exploring how the body responds to a new investigational capsule, and your participation could help pave the way for future therapies.